REFERENCES
- Todd KH, Green C, Bonham VL, et al. Sickle cell disease pain: crisis and conflict. J Pain. 2006;7:453–458.
- National Heart, Lung, and Blood Institute. Evidence-based management of sickle cell disease. 2014. Available at: http://www.nhlbi.nih.gov/guidelines. Accessed October 26, 2014.
- Brousseau DC, Owens PL, Mosso AL, et al. Acute care utilization and rehospitalizations for sickle cell disease. JAMA. 2010;303:1288–1294.
- Smith LA, Oyeku SO, Homer C, et al. Sickle cell disease: a question of equity and quality. Pediatrics. 2006;117:1763–1770.
- Darbari DS, Neely M, van den Anker J, et al. Increased clearance of morphine in sickle cell disease: implications for pain management. J Pain. 2011;12:531–538.
- Shapiro BS, Benjamin LJ, Payne R, et al. Sickle cell-related pain: perceptions of medical practitioners. J Pain Symptom Manage. 1997;14:168–174.
- Pack-Mabien A, Labbe E, Herbert D, et al. Nurses’ attitudes and practices in sickle cell pain management. Appl Nurs Res. 2001;14:187–192.
- Zempsky WT. Evaluation and treatment of sickle cell pain in the emergency department: paths to a better future. Clin Pediatr Emerg Med. 2010;11:265–273.
- McCarthy GC, Megall SA, Habib SA, et al. Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials. Drugs. 2010;20:1149–1163.
- Koppert W, Ostermeier N, Sittl R, et al. Low-dose lidocaine reduced secondary hyperalgesia by a central mode of action. Pain. 2000;85:217–224.
- Sugimoto M, Uchida I, Mashimo T. Local anaesthetics have different mechanisms and sites of action at the recombinant N-methyl-d-aspartate (NMDA) receptors. Br J Pharmacol. 2003;138:876–882.
- Sharma S, Rajagopal MR, Pala G, et al. A phase II pilot study to evaluate use of intravenous lidocaine for opioid-refractory pain in cancer patients. J Pain Symptom Manage. 2009;37:85–93.
- Schwartzman RJ, Patel M, Grothusen JR, et al. Efficacy of a 5-day continuous lidocaine infusion for the treatment of refractory complex regional pain syndrome. Pain Med. 2009;10: 401–412.
- Tremont-Lukats IW, Challapalli V, McNicol ED, et al. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg. 2005;101:1738–1749.
- National Comprehensive Cancer Network. Adult Cancer Pain (1.2015). Available at: http://www.nccn.org/professionals/ physician_gls/pdf/pain.pdf. Accessed March 26, 2015.
- Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20:4040–4049.
- DailyMed. Lidocaine hydrochloride injection. Available at: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid = 95e8a1e3-04c7-433f-ae8c-afa1c0d61deb. Accessed 14 November 2014.
- Thomas J, Kronenberg R, Craig M, et al. Intravenous lidocaine relieves severe pain: results of an inpatient hospice chart review. J Palliat Med. 2004;7:660–667.